News & Events
Updated: May 8, 2009
The U.S. Food and Drug Administration (FDA) is warning consumers to immediately stop using Hydroxycut products by Iovate Health Sciences, Inc., of Oakville, Ontario and distributed by Iovate Health Sciences U.S.A., Inc. of Blasdell, NY. Hydroxycut products are associated with a number of serious liver injuries.
The FDA has received 23 reports of serious health problems ranging from jaundice and elevated liver enzymes, an indicator of potential liver injury, to liver damage requiring liver transplants. One death due to liver failure has been reported to FDA. Other health problems reported include seizures; cardiovascular disorders; and rhabdomyolysis, a type of muscle damage that can lead to other serious health problems such as kidney failure.
Iovate Health Sciences U.S.A., Inc. Adds Hydroxycut-Branded Product Universal Product Codes to its Voluntary Nationwide Recall[ARCHIVED] Iovate Health Sciences U.S.A., Inc. Voluntarily Recalls Hydroxycut-Branded Products[ARCHIVED] Transcript of FDA Media Briefing on Hydroxycut Dietary Supplements(PDF - 44KB) Audio of FDA Media Briefing on Hydroxycut Dietary Supplements(MP3 - 3.8MB)